Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal that publishes high-quality research connecting molecular discoveries with clinical applications. The journal provides a platform for scientists, clinicians, and biomedical researchers to disseminate advances in translational medicine that improve understanding, diagnosis, and treatment of human diseases.

The journal aims to promote interdisciplinary research bridging basic molecular science and clinical medicine, enabling the translation of laboratory discoveries into improved patient care. The journal focuses on translational biomedical research integrating molecular biology, clinical medicine, and emerging biomedical technologies in the following research areas:

• Translational medicine

• Molecular and cellular biology

• Clinical biochemistry

• Genomics and epigenetics

• Proteomics and metabolomics

• Microbiome research

• Molecular oncology

• Neurobiology

• Biomarker discovery

• Drug discovery and resistance

• Gene and cell therapy

• Precision medicine

• Immunology and vaccinology

The mission of CMB is to promote research that moves discoveries from bench to bedside, accelerating the development of diagnostics, therapeutics, and personalized medicine. The journal is committed to rigorous, fair, and timely peer review by experts in the field. Clinical & Molecular Biomedicine adheres to the highest standards of research ethics, data reporting, and reproducibility, ensuring that all published work is both scientifically sound and clinically meaningful.

• Rigorous peer-review process

• Open access publishing

• No article processing charge (APC)

• Rapid editorial decision

• Global editorial board

• International authorship